| 1)The global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary diseases. Updated 2014. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Available from: http://www.goldcopd.org Accessed 11th February | 
							
								|  | 
							
								|   | 
						
							
								| 2)Christie JD, Edwards LB, Kucheryavaya AY, et al. International Society of Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012. J Heart Lung Transplant. 2012; 31: 1073-86 | 
							
								|     | 
							
								|   | 
						
							
								| 3)Trulock EP. Lung transplantation. Am J Respir Crit Care Med. 1997; 155: 789-818 | 
							
								|     | 
							
								|   | 
						
							
								| 4)Fishman A, Martinez F, Naunheim K, et al. National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003; 348: 2059-73 | 
							
								|     | 
							
								|   | 
						
							
								| 5)Gasparini S, Zuccatosta L, Bonifazi M, et al. Bronchoscopic treatment of emphysema: state of the art. Respiration. 2012; 84: 250-63 | 
							
								|     | 
							
								|   | 
						
							
								| 6)Shah PL, Herth FJ. Current status of bronchoscopic lung volume reduction with endobronchial valves. Thorax. 2014; 69: 280-6 | 
							
								|     | 
							
								|   | 
						
							
								| 7)Wan IYP, Toma TP, Geddes DM, et al. Bronchoscopic lung volume reduction for end-stage emphysema. Report on the first 98 patients. chest. 2006; 129: 518-26 | 
							
								|     | 
							
								|   | 
						
							
								| 8)Sciurba FC, Ernst A, Herth FJ, et al. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med. 2010; 363: 1233-44 | 
							
								|     | 
							
								|   | 
						
							
								| 9)Herth FJ, Noppen M, Valipour A, et al. Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort. Eur Respir J. 2012; 39: 1334-42 | 
							
								|     | 
							
								|   | 
						
							
								| 10)Sterman DH, Mehta AC, Wood DE, et al. A multicenter pilot study of a bronchial valve for the treatment of severe emphysema. Respiration. 2010; 79: 222-33 | 
							
								|     | 
							
								|   | 
						
							
								| 11)Ninane V, Geltner C, Bezzi M, et al. Multicentre European study for the treatment of advanced emphysema with bronchial valves. Eur Respir J. 2012; 39: 1319-25 | 
							
								|     | 
							
								|   | 
						
							
								| 12)Eberhardt R, Gompelmann D, Schuhmann M, et al. Complete unilateral vs partial bilateral endoscopic lung volume reduction in patients with bilateral lung emphysema. Chest. 2012; 142: 900-8 | 
							
								|     | 
							
								|   | 
						
							
								| 13)Aljuri N, Freitag L. Validation and pilot clinical study of a new bronchoscopic method to measure collateral ventilation before endobronchial lung volume reduction. J Appl Physiol. 2009; 106: 774-83 | 
							
								|  | 
							
								|   | 
						
							
								| 14)Herth FJ, Eberhardt R, Gompelmann D, et al. Radiological and clinical outcomes of using ChartisTM to plan endobronchial valve treatment. Eur Respir J. 2013; 41: 302-8 | 
							
								|     | 
							
								|   | 
						
							
								| 15)Mineshita M, Slebos DJ. Bronchoscopic interventions for chronic obstructive pulmonary disease. Respirology. 2014; 19: 1126-37 | 
							
								|   | 
							
								|   |